What You Should Know
- The Centers for Medicare & Medicaid Services (CMS) issued its FY 2027 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital (LTCH) PPS final rule, enacting a 2.3% net payment rate increase for both IPPS acute care hospitals and LTCHs.
- The rule mandates nationwide expansion of the Comprehensive Care for Joint Replacement (CJR) Model—dubbed CJR-X—beginning January 1, 2028, covering hip, knee, and ankle replacements across inpatient and hospital outpatient settings.
- CMS expects the payment updates and statutory policy shifts to increase overall IPPS hospital payments by ~$2.1 billion in FY 2027, with an additional $779 million allocated for new technology add-on payments (NTAP).
- Claims-based quality and readmission measures across the Hospital Inpatient Quality Reporting (IQR), Readmissions Reduction (HRRP), and Value-Based Purchasing (VBP) programs are modified to incorporate Medicare Advantage (MA) patient data and shorten reporting periods from 3 years to 2 years.
- Electronic Prior Authorization shifts to an optional bonus measure under the Medicare Promoting Interoperability Program for CY 2027 before becoming mandatory in CY 2028.
CMS Finalizes Mandatory Nationwide CJR-X and FY 2027 Inpatient Payment Rules
The hospital administration, revenue cycle management, and health policy sectors face a major regulatory pivot following the release of CMS’s FY 2027 Inpatient Prospective Payment System (IPPS) and Long-Term Care Hospital Prospective Payment System (LTCH PPS) final rule.
Acute care facilities continue to manage persistent non-labor cost inflation, shifting patient sites of care, and complex payer mix dynamics. In response, CMS is updating prospective payment rates while enforcing mandatory bundled care models and expanding quality measurement to reflect the broader Medicare population.
The finalized rule establishes a 2.3% net market basket update for IPPS acute care hospitals and standard LTCH discharges, projecting an aggregate $2.1 billion increase in IPPS payments for FY 2027. Concurrently, the agency is expanding alternative payment models by establishing CJR-X—a mandatory nationwide bundled payment framework for lower extremity joint replacements taking effect January 1, 2028.
CJR-X Expansion, Quality Reporting, and Interoperability
The FY 2027 final rule introduces several structural operational updates across clinical, financial, and IT workflows:
- Mandatory CJR-X Model Launch: Expands the Comprehensive Care for Joint Replacement framework nationwide starting January 1, 2028. CJR-X mandates bundled risk accountability for inpatient and hospital outpatient lower extremity joint replacements (hip, knee, and ankle).
- Integration of Medicare Advantage (MA) Data: Modifies claims-based mortality, excess days in acute care, and readmission measures across the IQR, HRRP, and VBP programs to include MA patient claims and shortens performance evaluation windows from 3 years to 2 years.
- Inpatient Quality Reporting (IQR) & eCQM Mandates: Adopts new electronic clinical quality measures (eCQMs)—including Postoperative Venous Thromboembolism and Advance Care Planning for FY 2030—while establishing mandatory reporting for the Malnutrition Care Score eCQM.
- Promoting Interoperability Adjustments: Positions Electronic Prior Authorization as an optional bonus measure in CY 2027 before making it mandatory in CY 2028. Adds mandatory reporting for Unique Device Identifiers (UDIs) for implantable medical devices starting in CY 2027.
- Graduate Medical Education (GME) Anti-Discrimination Standards: Codifies strict anti-discrimination requirements for approved medical residency, nursing, and allied health training programs as a condition of receiving Medicare GME reimbursement.
The nationwide rollout of mandatory CJR-X, combined with the inclusion of Medicare Advantage data into statutory quality and penalty programs, signals the end of siloed risk management. Hospitals can no longer maintain separate operational tracks for fee-for-service and Medicare Advantage patients.
Deploying automated clinical documentation tools, eCQM extraction engines, and AI-driven prior authorization workflows represents the most reliable mechanism for avoiding quality penalty cuts (such as IQR’s one-fourth update reduction or HRRP readmissions penalties) while maintaining operating margins under CJR-X.
This fact sheet discusses major provisions of the final rule, which can be downloaded from the Federal Register at: https://www.federalregister.gov/d/2026-15833.
